CLINICAL_TRIALS
trial_result
· 2021-03-05
Clinical Trial Update: Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia [Phase 1]
Summary
Phase 1 trial update of SGI-110 in patients with acute myeloid leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2021-03-05